Search Results

There are 8945 results for: content related to: Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies

  1. You have free access to this content
    The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease

    CNS Drug Reviews

    Volume 9, Issue 3, September 2003, Pages: 275–308, Michael A. Rogawski and Gary L. Wenk

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2003.tb00254.x

  2. You have free access to this content
    Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism.

    The Journal of Physiology

    Volume 499, Issue 1, February 15, 1997, Pages: 27–46, H S Chen and S A Lipton

    Version of Record online : 15 FEB 1997, DOI: 10.1113/jphysiol.1997.sp021909

  3. You have free access to this content
    Memantine binding to a superficial site on NMDA receptors contributes to partial trapping

    The Journal of Physiology

    Volume 587, Issue 19, October 2009, Pages: 4589–4604, Shawn E. Kotermanski, Jesse T. Wood and Jon W. Johnson

    Version of Record online : 29 SEP 2009, DOI: 10.1113/jphysiol.2009.176297

  4. You have free access to this content
    Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine – searching for the connections

    British Journal of Pharmacology

    Volume 167, Issue 2, September 2012, Pages: 324–352, Wojciech Danysz and Chris G Parsons

    Version of Record online : 22 AUG 2012, DOI: 10.1111/j.1476-5381.2012.02057.x

  5. Memantine reduces alcohol drinking but not relapse in alcohol-dependent rats

    Addiction Biology

    Volume 20, Issue 5, September 2015, Pages: 890–901, Stéphanie Alaux-Cantin, Romain Buttolo, Hakim Houchi, Jérôme Jeanblanc and Mickaël Naassila

    Version of Record online : 20 AUG 2014, DOI: 10.1111/adb.12177

  6. You have free access to this content
    Effects of the Non-Competitive NMDA Receptor Antagonist Memantine on the Volitional Consumption of Ethanol by Alcohol-Preferring Rats

    Basic & Clinical Pharmacology & Toxicology

    Volume 106, Issue 5, May 2010, Pages: 435–444, Gloria E. Malpass, Helen L. Williams and Brian A. McMillen

    Version of Record online : 22 FEB 2010, DOI: 10.1111/j.1742-7843.2010.00544.x

  7. Pharmacokinetic Properties of Memantine Following a Single Intraperitoneal Administration and Multiple Oral Doses in Euploid Mice and in the Ts65Dn Mouse Model of Down's Syndrome

    Basic & Clinical Pharmacology & Toxicology

    Accepted manuscript online: 30 MAY 2017, Daniella B. Victorino, Ilya R. Bederman and Alberto C. S. Costa

    DOI: 10.1111/bcpt.12816

  8. You have free access to this content
    Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices

    British Journal of Pharmacology

    Volume 117, Issue 4, February 1996, Pages: 689–697, Tadeusz Frankiewicz, Brigitte Potier, Zafar I. Bashir, Graham L. Collingridge and Chris G. Parsons

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1996.tb15245.x

  9. A review of the effects of memantine on clinical progression in Alzheimer's disease

    International Journal of Geriatric Psychiatry

    Volume 27, Issue 8, August 2012, Pages: 769–776, David Wilkinson

    Version of Record online : 1 OCT 2011, DOI: 10.1002/gps.2788

  10. You have free access to this content
    Modulation of NMDA effects on agonist-stimulated phosphoinositide turnover by memantine in neonatal rat cerebral cortex

    British Journal of Pharmacology

    Volume 114, Issue 4, February 1995, Pages: 797–804, Rajendra Mistry, Rolf Wilke and R.A. John Challiss

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1995.tb13275.x

  11. You have free access to this content
    MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway

    British Journal of Pharmacology

    Volume 172, Issue 9, May 2015, Pages: 2354–2368, Guoqi Zhu, Junyao Li, Ling He, Xuncui Wang and Xiaoqi Hong

    Version of Record online : 26 MAR 2015, DOI: 10.1111/bph.13061

  12. Rationale for Combination Therapy With Galantamine and Memantine in Alzheimer's Disease

    The Journal of Clinical Pharmacology

    Volume 46, Issue S1, July 2006, Pages: 17S–26S, Dr George T. Grossberg, Dr Keith R. Edwards and Dr Qinying Zhao

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006288735

  13. Simultaneous determination of memantine and amantadine in human plasma as fluorescein derivatives by micellar electrokinetic chromatography with laser-induced fluorescence detection and its clinical application

    ELECTROPHORESIS

    Volume 31, Issue 11, June 2010, Pages: 1903–1911, Hsin-Hua Yeh, Yuan-Han Yang and Su-Hwei Chen

    Version of Record online : 5 MAY 2010, DOI: 10.1002/elps.201000001

  14. Steady-State Pharmacokinetics of Galantamine Are Not Affected by Addition of Memantine in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 519–528, Dr Caiping Yao, Dr Arash Raoufinia, Dr Michael Gold, Dr Jeffrey S. Nye, Dr Steven Ramael, Mr Mukund Padmanabhan, Dr Yolande Walschap, Dr Tom Verhaeghe and Dr Qinying Zhao

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270005274551

  15. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

    International Journal of Geriatric Psychiatry

    Volume 23, Issue 5, May 2008, Pages: 537–545, S. Gauthier, H. Loft and J. Cummings

    Version of Record online : 3 DEC 2007, DOI: 10.1002/gps.1949

  16. You have free access to this content
    Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel

    British Journal of Pharmacology

    Volume 172, Issue 5, March 2015, Pages: 1333–1347, Christine M Emnett, Lawrence N Eisenman, Jayaram Mohan, Amanda A Taylor, James J Doherty, Steven M Paul, Charles F Zorumski and Steven Mennerick

    Version of Record online : 13 JAN 2015, DOI: 10.1111/bph.13007

  17. The place of memantine in the treatment of Alzheimer's disease: a number needed to treat analysis

    International Journal of Geriatric Psychiatry

    Volume 19, Issue 10, October 2004, Pages: 919–925, Gill Livingston and Cornelius Katona

    Version of Record online : 27 SEP 2004, DOI: 10.1002/gps.1166

  18. Memantine delayed N-methyl-D-aspartate -induced convulsions in neonatal rats

    Fundamental & Clinical Pharmacology

    Volume 29, Issue 1, February 2015, Pages: 72–78, Ashish Dhir and Kanwaljit Chopra

    Version of Record online : 2 DEC 2014, DOI: 10.1111/fcp.12090

  19. You have free access to this content
    Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes

    The Journal of Physiology

    Volume 586, Issue 1, January 2008, Pages: 211–225, David C. Wrighton, Edward J. Baker, Philip E. Chen and David J. A. Wyllie

    Version of Record online : 2 JAN 2008, DOI: 10.1113/jphysiol.2007.143164

  20. Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD

    International Journal of Geriatric Psychiatry

    Volume 27, Issue 6, June 2012, Pages: 651–656, Rainer Hellweg, Yvonne Wirth, Wolfgang Janetzky and Susanne Hartmann

    Version of Record online : 25 AUG 2011, DOI: 10.1002/gps.2766